Nailesh Bhatt serves as Executive at Sonnet BioTherapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Nailesh Bhatt has executed 9 insider transactions totaling $5.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 9, 2026 involved receiving (via award) 40,789 shares valued at $0.
Nailesh Bhatt currently holds 42,871 shares of Sonnet BioTherapeutics Holdings, Inc. (SONN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nailesh Bhatt has been a net buyer of SONN stock. They have purchased $5.8K and sold $0 worth of shares.
Nailesh Bhatt's most recent insider trade was on Feb 9, 2026, when they sold 40,789 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 2, 2025 | PURR | $0 | Other | 2,082 | $N/A | Discretionary |
| Jul 11, 2025 | SONN | $0 | Award | 10,000 | $N/A | Discretionary |
| May 17, 2023 | SONN | $5.8K | Purchase | 25,000 | $0.23 | Discretionary |
| Dec 14, 2022 | SONN | $0 | Award | 3,770 | $N/A | Discretionary |
| Dec 15, 2021 | SONN | $0 | Award | 14,152 | $N/A | Discretionary |
| Jul 2, 2020 | SONN | $0 | Award | 8,005 | $N/A | Discretionary |
| Apr 1, 2020 | SONN | $0 | Award | 5,328 | $N/A | Discretionary |